Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

BACKGROUND: Fluticasone furoate is a once-daily inhaled corticosteroid. This report provides an overview of safety and efficacy data that support the use of once-daily fluticasone furoate 100 μg or 200 μg in adult and adolescent asthma patients. METHODS: Fourteen clinical studies (six Phase II and e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Respir Res
Hlavní autoři: O’Byrne, Paul M., Jacques, Loretta, Goldfrad, Caroline, Kwon, Namhee, Perrio, Michael, Yates, Louisa J., Busse, William W.
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5122018/
https://ncbi.nlm.nih.gov/pubmed/27881132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0473-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky